Ingredients in the Early Development of the U.S. Biotechnology Industry

Small Business Economics

Volumn 17, Issue 1-2, 2001, Pages 17-29

  Prevezer, Martha ^a  

^a LONDON SOUTH BANK UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0035627196     PISSN: 0921898X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011174421603     Document Type: Article

References (33)

1. Arora, A. and A. Gambardella, 1993, 'The Division of Innovative Labour in Biotechnology', in H. John Heinz III School of Public Policy and Management, Working Paper, Pittsburgh: Carnegie Mellon.
2. Audretsch, D. and P. Stephen, 1996, 'Company-Scientist Locational Links: The Case of Biotechnology', American Economic Review 86(3), 641-652.
3. Barley, S., J. Freeman and R. C. Hybels, 1992, 'Strategic Alliances in Commercial Biotechnology', in N. Nohria and R. Eccles (eds.), Networks and Organizations: Structure, Form and Action, Boston, MA: Harvard Business School Press.
4. Beecroft, A., 1994, 'The Role of the Venture Capital Industry in the UK', in N. Dimsdale and M. Prevezer (eds.), Capital Markets and Corporate Governance, Oxford: Oxford University Press.
5. Cohen, W. M. and D. A. Levinthal, 1990, 'Absorptive Capacity: A New Perspective on Learning and Innovation', Administrative Science Quarterly 35(1), 128-152.
6. Dibner, M. D., 1988, Bio/Technology, pp. 276-279.
7. Dibner, M. D., 1991, Biotechnology Guide U.S.A., Companies, Data and Analysis, New York: Macmillan.
8. Dimsdale, N. and M. Prevezer (eds.), 1994, Capital Markets and Corporate Governance, Oxford: Oxford University Press.
9. Dodgson, M., 1991, 'Strategic Alignment and Organizational Options in Biotechnology Firms', Technology Analysis and Strategic Management 3(2), 115-125.
10. Ernst & Young, 1992, Biotech 93: Accelerating Commercialization, San Francisco: Ernst & Young.
11. Ernst & Young, 1988, Biotech 89: Commercialization, San Francisco: Ernst & Young.
12. Giesecke, S., 2000, 'The Contrasting Roles of Government in the Development of Biotechnology Industry in the U.S. and Germany', Research Policy 29, 205-223.
13. Hagedoorn, J. and J. Schakenraad, 1990, 'Interfirm Partnerships and Cooperative Strategies in Core Technologies', in C. Freeman and L. Soete (eds.), New Explorations in the Economics of Technical Change, London and New York: Pinter.
14. Hall, S., 1987, Invisible Frontiers: The Race to Synthesize a Human Gene, London: Sidgwick and Jackson.
15. Kenney, M., 1986, Biotechnology: The University-Industrial Complex, New Haven, CT: Yale University Press.
16. Levin, R., A. Klevorick, R. Nelson and S. Winter, 1987, 'Appropriating the Returns from Industrial Research and Development', Brookings Papers on Economic Activity 3, 783-820.
17. McKelvey, M., 1994, Evolutionary Innovation: Early Industrial Uses of Genetic Engineering, Linkoping: Department of Technology and Social Change.
18. National Economic Development Office (NEDO), 1991, New Life for Industry; Biotechnology, Industry and the Community in the 1990s and Beyond, National Economic Development Council.
19. Orsenigo, L., 1989, The Emergence of Biotechnology, London: Pinter.
20. Orsenigo, L., F. Pammolli and M. Riccaboni, forthcoming, 'Technological Change and Network Dynamics. Lessons from the Pharmaceutical Industry', Research Policy.
21. Powell, W. and P. Brantley, 1992, 'Competitive Cooperation in Biotechnology: Learning Through Networks', in N. Nohria and R. Eccles (eds.), Networks and Organizations: Structure, Form and Action, Boston, MA: Harvard Business School Press.
22. Prevezer, M., 1996, 'The Dynamics of Industrial Clustering in Biotechnology', Small Business Economics 8, 1-17.
23. Prevezer, M. and S. Toker, 1996, 'The Degree of Integration in Strategic Alliances in Biotechnology', Technology Analysis and Strategic Management 8(2).
24. Prevezer, M. and S. Shohet, 1996 'New Knowledge: Production v. Diffusion; the Case of U.K. Biotechnology', Centre for Business Strategy Working Paper, Number 162, London Business School.
25. Prevezer, M., 1998, 'Clustering in Biotechnology in the U.S.A.', in P. Swann, M. Prevezer and D. Stout (eds.), The Dynamics of Industrial Clustering. International Comparisons in Computing and Biotechnology, Oxford: Oxford University Press.
26. Saxenian, A., 1994, Regional Advantage, Cambridge, MA: Harvard University Press.
27. Sharp, M., 1985, The New Biotechnology: European Governments in Search of a Strategy, Sussex European Papers No. 15, Brighton: University of Sussex.
28. Sharp, M., 1991, 'Technological Trajectories and Corporate Strategies in the Diffusion of Biotechnology', in E. Deico, E. Hornell and G. Vickery (eds.), Technology and Investment: Crucial Issues for the 1990s, London: Pinter Publishers.
29. Shohet, S. and M. Prevezer, 1996, 'U.K. Biotechnology: Institutional Linkages, Technology Transfer and the Role of Intermediaries', R&D Management 26(3).
30. Swann, P., M. Prevezer and D. Stout, 1998, The Dynamics of Industrial Clustering. International Comparisons in Computing and Biotechnology, Oxford: Oxford University Press.
31. Teitelman R., 1989, Gene Dreams: Wall Street, Academia and the Rise of Biotechnology, New York: Basic Books Inc.
32. Zucker, L., M. Darby and M. Brewer, 1994, 'Intellectual Capital and the Birth of U.S. Biotechnology Enterprises', National Bureau of Economic Research Working Paper 4653, Cambridge, MA.
33. Zucker, L. and M. Darby, 1995, 'Virtuous Circles of Productivity: Star Bioscientists and the Institutional Transformation of Industry', National Bureau of Economic Research Working Paper 5342, Cambridge, MA.